FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2736865764> ?p ?o ?g. }

• W2736865764 endingPage "111" @default.
• W2736865764 startingPage "104" @default.
• W2736865764 abstract "Los bifosfonatos constituyen una familia de medicamentos cuya acción principal es la inhibición de la reabsorción ósea, uno de cuyos efectos secundarios es la osteonecrosis maxilar (OMAB). En 2010 comenzaron a publicarse casos de osteonecrosis asociados a un nuevo fármaco, el denosumab. En 2014 se recomendó cambiar el nombre de OMAB por osteonecrosis maxilar asociada a medicamentos (OMAM). El objetivo de este trabajo es revisar una serie de casos de OMAM tratados en nuestro servicio y reflejar la experiencia adquirida con las distintas opciones terapéuticas según la clasificación clínica definida por la American Association of Oral and Maxillofacial Surgeons (AAOMS). Se recogió retrospectivamente un grupo de 19 pacientes con diagnóstico de OMAM, manejados desde 2005 hasta 2015. Su estadio fue determinado según la clasificación de la AAOMS y Ruggiero. Las lesiones fueron tratadas según sus características clínicas y radiológicas. Su edad media fue de 75 años. La enfermedad de base era osteoporosis en 11 pacientes (58%), cáncer de próstata en 2 (11%), cáncer de mama en otrod 2 (11%) y mieloma múltiple en 4 pacientes (20%). En 9 pacientes el bifosfonato utilizado era intravenoso (47%); en los 4 restantes se usó la vía oral (alendronato e ibandronato, 21%) y el denosumab se administra por vía subcutánea. Los pacientes en estadio 3 fueron tratados en todos los casos con mandibulectomía segmentaria. Tres de ellos fueron reconstruidos con colgajo microquirúrgico de peroné y uno con barra mandibular más cierre directo. Fueron tratados mediante secuestrectomía 7 pacientes, de los cuales 5 tenían estadio 2 y 2 tenían estadio 1. Con desbridamiento local solo fue tratado un paciente, que presentaba estadio 1. El tratamiento conservador se aplicó al resto de los pacientes estadio 1 (4 pacientes) y a 3 pacientes del estadio 2. El tratamiento de la OMAM depende del estadio de la enfermedad; la mandibulectomía es un tratamiento efectivo en el estadio 3 y la secuestrectomía en el estadio 2; el estadio 1 suele controlarse con tratamiento conservador. Bisphosphonates are a family of drugs used to inhibit bone resorption. One of their secondary effects is osteonecrosis of the jaws (ONJ). In 2010, scientists began to publish cases of osteonecrosis of the jaws associated with a new drug, denosumab. In 2014 it was recommended to change the name of ONJ to medication-related osteonecrosis of the jaws (MONJ). The aim of this article is to review a case series of MONJ treated in our Department, and present our experience in the different treatment options according to the clinical classification defined by the American Association of Oral Maxillofacial Surgeons (AAOMS). A retrospective review was performed on 19 patients with MONJ, who were managed between 2005 and 2015. The clinical staging was according to the classification of the AAOMS and Ruggiero. The lesions were treated according to their clinical and radiological presentation. The mean age was 75 years. The underlying disease was osteoporosis in 11 patients (58%), prostate cancer in 2 patients (11%), breast cancer in 2 patients (11%), and multiple myeloma in 4 patients (20%). Intravenous bisphosphonates were used in 9 (47%) patients, and oral in the remaining 4 (alendronate and ibandronate, 21%), with denosumab being administered subcutaneously. Stage 3 patients were treated in all cases with segmental mandibulectomy. Three of them were re-constructed with a microsurgical fibula flap, and onw with bar and direct closure. Sequestrectomy was used to treat 7 patients, of which 5 had stage 2, and 2 stage 1. One patient with stage 1 was treated with local debridement. Conservative treatment was applied to the rest (4) of the stage 1 patients, and 3 stage 2 patients. Mandibulectomy is an effective treatment for stage 3, sequestrectomy for stage 2, and conservative measures for stage 1. This pathology is also associated with other drugs, such as denosumab, which is why the term had changed to medication-related osteonecrosis of the jaw. MONJ treatment depends on the stage of the disease, with mandibulectomy being an effective treatment in stage 3, sequestrectomy in stage 2 and stage 1 is usually controlled with conservative treatment." @default.
• W2736865764 created "2017-07-31" @default.
• W2736865764 creator A5007291177 @default.
• W2736865764 creator A5033062868 @default.
• W2736865764 creator A5038274248 @default.
• W2736865764 creator A5048573111 @default.
• W2736865764 creator A5080890037 @default.
• W2736865764 creator A5083586275 @default.
• W2736865764 date "2018-07-01" @default.
• W2736865764 modified "2023-10-06" @default.
• W2736865764 title "Manejo de la osteonecrosis maxilar asociada al uso de medicamentos en virtud de su estadio clínico: análisis de 19 casos" @default.
• W2736865764 cites W1975068146 @default.
• W2736865764 cites W1977795297 @default.
• W2736865764 cites W1988260211 @default.
• W2736865764 cites W1991756041 @default.
• W2736865764 cites W1995807081 @default.
• W2736865764 cites W1996433976 @default.
• W2736865764 cites W2008203305 @default.
• W2736865764 cites W2026918071 @default.
• W2736865764 cites W2043133670 @default.
• W2736865764 cites W2053285793 @default.
• W2736865764 cites W2055293789 @default.
• W2736865764 cites W2058889454 @default.
• W2736865764 cites W2090064140 @default.
• W2736865764 cites W2107208293 @default.
• W2736865764 cites W2108103914 @default.
• W2736865764 cites W2110711752 @default.
• W2736865764 cites W2133503719 @default.
• W2736865764 cites W2138072619 @default.
• W2736865764 cites W2140741067 @default.
• W2736865764 cites W2143254775 @default.
• W2736865764 cites W2162655600 @default.
• W2736865764 cites W2166623891 @default.
• W2736865764 cites W2169512870 @default.
• W2736865764 cites W2381595276 @default.
• W2736865764 cites W2513579707 @default.
• W2736865764 cites W45400945 @default.
• W2736865764 doi "https://doi.org/10.1016/j.maxilo.2017.06.001" @default.
• W2736865764 hasPublicationYear "2018" @default.
• W2736865764 type Work @default.
• W2736865764 sameAs 2736865764 @default.
• W2736865764 citedByCount "6" @default.
• W2736865764 countsByYear W27368657642021 @default.
• W2736865764 countsByYear W27368657642023 @default.
• W2736865764 crossrefType "journal-article" @default.
• W2736865764 hasAuthorship W2736865764A5007291177 @default.
• W2736865764 hasAuthorship W2736865764A5033062868 @default.
• W2736865764 hasAuthorship W2736865764A5038274248 @default.
• W2736865764 hasAuthorship W2736865764A5048573111 @default.
• W2736865764 hasAuthorship W2736865764A5080890037 @default.
• W2736865764 hasAuthorship W2736865764A5083586275 @default.
• W2736865764 hasBestOaLocation W27368657641 @default.
• W2736865764 hasConcept C126322002 @default.
• W2736865764 hasConcept C138885662 @default.
• W2736865764 hasConcept C15708023 @default.
• W2736865764 hasConcept C2776286101 @default.
• W2736865764 hasConcept C2776541429 @default.
• W2736865764 hasConcept C2777251235 @default.
• W2736865764 hasConcept C2777556957 @default.
• W2736865764 hasConcept C29456083 @default.
• W2736865764 hasConcept C71924100 @default.
• W2736865764 hasConceptScore W2736865764C126322002 @default.
• W2736865764 hasConceptScore W2736865764C138885662 @default.
• W2736865764 hasConceptScore W2736865764C15708023 @default.
• W2736865764 hasConceptScore W2736865764C2776286101 @default.
• W2736865764 hasConceptScore W2736865764C2776541429 @default.
• W2736865764 hasConceptScore W2736865764C2777251235 @default.
• W2736865764 hasConceptScore W2736865764C2777556957 @default.
• W2736865764 hasConceptScore W2736865764C29456083 @default.
• W2736865764 hasConceptScore W2736865764C71924100 @default.
• W2736865764 hasIssue "3" @default.
• W2736865764 hasLocation W27368657641 @default.
• W2736865764 hasOpenAccess W2736865764 @default.
• W2736865764 hasPrimaryLocation W27368657641 @default.
• W2736865764 hasRelatedWork W128988122 @default.
• W2736865764 hasRelatedWork W1975068146 @default.
• W2736865764 hasRelatedWork W2009758340 @default.
• W2736865764 hasRelatedWork W2179631743 @default.
• W2736865764 hasRelatedWork W2734610622 @default.
• W2736865764 hasRelatedWork W2792959959 @default.
• W2736865764 hasRelatedWork W2885306669 @default.
• W2736865764 hasRelatedWork W3024011741 @default.
• W2736865764 hasRelatedWork W3034705853 @default.
• W2736865764 hasRelatedWork W4247326581 @default.
• W2736865764 hasVolume "40" @default.
• W2736865764 isParatext "false" @default.
• W2736865764 isRetracted "false" @default.
• W2736865764 magId "2736865764" @default.
• W2736865764 workType "article" @default.